n.a. (LO)

pos +0.00
Today's Range: 0.00 - 0.00 | LO Avg Daily Volume: 0
Last Update: 12/31/69 - 7:00 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $0.00
52 Week Range: $0.00 - $0.00
Oustanding Shares: 360,328,000
Market Cap: 0
6-Month Chart
TheStreet Ratings Grade for LO
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
LO Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for LO:
Revenue 0.00B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.94 $1.00 $3.77 $4.09
Number of Analysts 5 3 6 6
High Estimate $0.97 $1.01 $3.85 $4.22
Low Estimate $0.91 $0.99 $3.67 $3.89
Prior Year $0.84 $0.90 $3.36 $3.77
Growth Rate (Year over Year) 12.14% 11.11% 12.30% 8.26%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Check out these Thanksgiving week dividends.

Finding a Place to Hide Real Money Pro($)

My strategy for when markets get choppy.
Here are top names set to go ex-dividend over the next two weeks.

Dividend D-Days Real Money Pro($)

We have one coming up next week.

Who Will Be Bought Next? Real Money Pro($)

M&A activity is in full swing, so watch these companies.
A wave of M&A in the health sector makes sense.
It isn't based on complacency; it's based on the facts.

Dividend D-Day Alert Real Money Pro($)

It's one of those times when a huge number of declared dividends will go ex.
The potential legalization of marijuana is not enough to justify these prices.

Columnist Conversations

Raytheon is building on Tuesday's impressive breakout.  The defense name is up over 1.25% ahead of tonigh...
Merck had a nice earnings beat on Tuesday which was accompanied by an earlier than expected FDA approval on Ke...
For years Apple was accused of under promise, over deliver --- UPOD as Jim Cramer likes to call it.  Whil...
Market down across the board, as less than optimistic outlook from Apple (AAPL) dampens investor enthusiasm in...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.